ArticleOncogene2019

Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells.

Paul Dent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.